EntreChem, S.L. was founded in 2006 as an entrepreneurial venture by University Professors and a scientist-turned entrepreneur. EntreChem is focused on drug discovery and development for human health, especially in cancer. We have raised a mixture of public and private funding in excess of 9MEUR since inception.
Seed capital funding funding by co-founders acted as a catalyst for a syndicate of public agencies that provided competitive R&D soft loans and grants, at the local, national and european level. National agencies like Genoma España and CDTI (Centro para el Desarrollo Tecnológico Industrial) through its NEOTEC program, together with local development agencies (IDEPA, FICYT and SRP) and various programs from the Ministry of Economy and the European Union FP6, FP7 and H2020 programs, provided funding through the early years of the start-up period.
In year 2010, reflecting our growth expectations, we attracted private capital from several local family offices and business angels. This support was renewed in 2012 and in 2015, especially by the Alimerka family office, helping us navigate the preclinical space towards the clinical stage and witnessing firsthand the exciting opportunities ahead of us.
In 2021, with two drug programs ready for clinical trials, local financing sources have dried up, causing EntreChem SL to enter insolvency proceedings. We are at present looking for solutions to solve the situation.
For more information and inquires, please contact us
